List of bibliographic references indexed by model
Number of relevant bibliographic references: 180.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000016 (2017) |
P Githure M'Angale [Canada] ; Brian E. Staveley [Canada] | The HtrA2 Drosophila model of Parkinson's disease is suppressed by the pro-survival Bcl-2 Buffy. |
| 000075 (2017) |
Fábio G. Teixeira [Portugal] ; Miguel M. Carvalho [Portugal] ; Krishna M. Panchalingam [Canada] ; Ana J. Rodrigues [Portugal] ; Bárbara Mendes-Pinheiro [Portugal] ; Sandra Anjo [Portugal] ; Bruno Manadas [Portugal] ; Leo A. Behie [Canada] ; Nuno Sousa [Portugal] ; Ant Nio J. Salgado [Portugal] | Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease. |
| 000127 (2017) |
Chi Wang Ip [Allemagne] ; Laura-Christin Klaus [Allemagne] ; Akua A. Karikari [Allemagne] ; Naomi P. Visanji ; Jonathan M. Brotchie ; Anthony E. Lang ; Jens Volkmann [Allemagne] ; James B. Koprich | AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson’s disease |
| 000153 (2016) |
Qing He [République populaire de Chine] ; James B. Koprich [Canada] ; Ying Wang [République populaire de Chine] ; Wen-Bo Yu [République populaire de Chine] ; Bao-Guo Xiao [République populaire de Chine] ; Jonathan M. Brotchie [Canada] ; Jian Wang [République populaire de Chine] | Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease. |
| 000157 (2016) |
James B. Koprich [Canada] ; Tom H. Johnston [Canada] ; Gabriela Reyes [Canada] ; Vanessa Omana [Canada] ; Jonathan M. Brotchie [Canada] | Towards a Non-Human Primate Model of Alpha-Synucleinopathy for Development of Therapeutics for Parkinson’s Disease: Optimization of AAV1/2 Delivery Parameters to Drive Sustained Expression of Alpha Synuclein and Dopaminergic Degeneration in Macaque |
| 000158 (2016) |
Roberto C. Sotero | Topology, Cross-Frequency, and Same-Frequency Band Interactions Shape the Generation of Phase-Amplitude Coupling in a Neural Mass Model of a Cortical Column |
| 000264 (2016) |
Imène Achour [Canada] ; Anne-Marie Arel-Dubeau [Canada] ; Justine Renaud [Canada] ; Manon Legrand [Canada] ; Everaldo Attard [Malte] ; Marc Germain [Canada] ; Maria-Grazia Martinoli [Canada] | Oleuropein Prevents Neuronal Death, Mitigates Mitochondrial Superoxide Production and Modulates Autophagy in a Dopaminergic Cellular Model. |
| 000273 (2016) |
Mohammed Filali [Canada] ; Robert Lalonde [France] | Neurobehavioral Anomalies in the Pitx3/ak Murine Model of Parkinson's Disease and MPTP. |
| 000281 (2016) |
Shichun Peng [États-Unis] ; Yilong Ma [États-Unis] ; Joseph Flores [Canada] ; Michael Cornfeldt [États-Unis] ; Branka Mitrovic [États-Unis] ; David Eidelberg [États-Unis] ; Doris J. Doudet [Canada] | Modulation of Abnormal Metabolic Brain Networks by Experimental Therapies in a Nonhuman Primate Model of Parkinson Disease: An Application to Human Retinal Pigment Epithelial Cell Implantation |
| 000361 (2016) |
S. Al-Sweidi [Canada] ; M. Morissette [Canada] ; T. Di Paolo [Canada] | Estrogen receptors modulate striatal metabotropic receptor type 5 in intact and MPTP male mice model of Parkinson's disease. |
| 000446 (2016) |
E M Merzetti [Canada] ; B E Staveley [Canada] | Altered expression of CG5961, a putative Drosophila melanogaster homologue of FBXO9, provides a new model of Parkinson disease. |
| 000455 (2016) |
Christian Duval [Canada] ; Jean-Francois Daneault [États-Unis] ; William D. Hutchison [Canada] ; Abbas F. Sadikot [Canada] | A brain network model explaining tremor in Parkinson's disease. |
| 000481 (2015) |
Anja Meissner ; Naomi P. Visanji ; M Abdul Momen ; Rui Feng ; Beverly M. Francis ; Steffen-Sebastian Bolz ; Lili-Naz Hazrati | Tumor Necrosis Factor-α Underlies Loss of Cortical Dendritic Spine Density in a Mouse Model of Congestive Heart Failure |
| 000488 (2015) |
Janelle Drouin-Ouellet ; Isabelle St-Amour ; Martine Saint-Pierre ; Jérôme Lamontagne-Proulx ; Jasna Kriz ; Roger A. Barker ; Francesca Cicchetti | Toll-Like Receptor Expression in the Blood and Brain of Patients and a Mouse Model of Parkinson’s Disease |
| 000508 (2015) |
Jackalina M. Van Kampen [Canada] ; David C. Baranowski [Canada] ; Harold A. Robertson [Canada] ; Christopher A. Shaw [Canada] ; Denis G. Kay [Canada] | The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease |
| 000587 (2015) |
Abid Oueslati [Suisse, Canada] ; Blaise Lovisa [Suisse] ; John Perrin [Suisse] ; Georges Wagnières [Suisse] ; Hubert Van Den Bergh [Suisse] ; Yanik Tardy [Suisse] ; Hilal A. Lashuel [Suisse, Qatar] | Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson’s Disease |
| 000610 (2015) |
Jihye Park [Corée du Sud] ; Chae-Seok Lim [Corée du Sud] ; Hyunhyo Seo [Corée du Sud] ; Chung-Ah Park [Corée du Sud] ; Min Zhuo [Canada] ; Bong-Kiun Kaang [Corée du Sud] ; Kyungmin Lee [Corée du Sud] | Pain perception in acute model mice of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) |
| 000655 (2015) |
Kyle Farmer ; Catherine A. Smith ; Shawn Hayley ; Jeffrey Smith | Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson’s Disease |
| 000663 (2015) |
Galit Saar [États-Unis] ; Ning Cheng [États-Unis, Canada] ; Leonardo Belluscio [États-Unis] ; Alan P. Koretsky [États-Unis] | Laminar Specific Detection of APP induced Neurodegeneration and Recovery using MEMRI in an Olfactory based Alzheimer’s Disease Mouse Model |
| 000676 (2015) |
Alfonso Fasano [Canada] ; Louis W C. Liu ; Yu-Yan Poon ; Antony E. Lang | Initiating intrajejunal infusion of levodopa/carbidopa intestinal gel: an outpatient model. |
| 000678 (2015) |
Ross B. Mounsey [Royaume-Uni] ; Sarah Mustafa [Royaume-Uni] ; Lianne Robinson [Royaume-Uni] ; Ruth A. Ross [Canada] ; Gernot Riedel [Royaume-Uni] ; Roger G. Pertwee [Royaume-Uni] ; Peter Teismann [Royaume-Uni] | Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "model"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "model" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= model
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 |  |
